Atlas Trials

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

Clinical trial NCT01919229 · TERMINATED

Trial details

NCT number
NCT01919229
Sponsor
Novartis Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Early Breast Cancer
Start date
2013-10-01
Primary completion
2014-09-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.